Spanish hospitals track Real-World use of potassium drug

NCT ID NCT06635499

Completed Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how doctors in 20 Spanish hospitals use the drug Lokelma to treat patients with high potassium levels (hyperkalemia). Researchers collected information from 232 patients' medical records to understand how the drug is prescribed and how patients respond in real life. The goal was to learn about treatment patterns and outcomes, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERKALAEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hyperkalemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERKALAEMIA

Contacts and locations

Locations

Research Site

A Coruña, Spain
Research Site

Asturias, Spain
Research Site

Badajoz, Spain
Research Site

Barcelona, Spain
Research Site

Burgos, Spain
Research Site

Cadiz, Spain
Research Site

Córdoba, Spain
Research Site

Huelva, Spain
Research Site

Lleida, Spain
Research Site

Madrid, Spain
Research Site

Málaga, Spain
Research Site

Santa Cruz de Tenerife, Spain
Research Site

Valencia, Spain
Research Site

Zaragoza, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.